Literature DB >> 1944108

Low-grade astrocytomas of childhood.

H L Rekate1, S M Rakfal.   

Abstract

Low-grade astrocytomas are the single most common form of pediatric brain tumor, representing 28% of the total. Prolonged survival and even cures can be expected in a substantial proportion of patients who present with these tumors. For a variety of reasons, the overall oncologic management of children with low-grade astrocytomas is extremely controversial. This article analyzes the available information related to the management of various forms of low-grade astrocytoma in childhood while awaiting the performance of a long-term national cooperative study on the natural history and management of this common pediatric brain tumor.

Entities:  

Mesh:

Year:  1991        PMID: 1944108

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

Review 1.  Pilomyxoid astrocytoma: a review.

Authors:  Ricardo J Komotar; J Mocco; Benjamin S Carson; Michael E Sughrue; Brad E Zacharia; Alexander C Sisti; Peter D Canoll; Alexander G Khandji; Tarik Tihan; Peter C Burger; Jeffery N Bruce
Journal:  MedGenMed       Date:  2004-12-09

Review 2.  Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part I: Introduction to MRS.

Authors:  S E Byrd; T Tomita; P S Palka; C F Darling; J P Norfray; J Fan
Journal:  J Natl Med Assoc       Date:  1996-10       Impact factor: 1.798

Review 3.  Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.

Authors:  Gianluca Trevisi; Thomas Roujeau; Hugues Duffau
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

4.  Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma.

Authors:  M A Pons; J L Finlay; R W Walker; D Puccetti; R J Packer; M McElwain
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.